Incivo (telaprevir) Important Safety Information from Janssen as approved by the Irish Medicines Board

Notice type: 3rd Party Publications

Date: 09/04/2013

 

Problem Or Issue:
Important Safety Information communication from Janssen on management of severe cutaneous adverse reactions (SCAR) with Incivo (telaprevir).

Important Safety Information - Incivo (telaprevir)


« Back